Dr. Girard is an Associate Professor at Duke-NUS in Singapore. He is currently heading the Ophthalmic Engineering & Innovation Laboratory (OEIL) at the Singapore Eye Research Institute (SERI). He also Co-Heads the Bioengineering & Devices Research Group. Dr. Girard has strong expertise in Ophthalmic Engineering with a focus on Artificial Intelligence, Biomedical Imaging, Ocular Biomechanics, and Ophthalmic Devices. His research has especially focused on optic neuropathies (including glaucoma) and myopia, corneal disorders, and cataracts. Dr. Girard's research has remained translational. He is the founder of the Singapore start-up company Abyss Processing Pte Ltd, which provides 3D AI solutions to simplify and improve glaucoma diagnosis & prognosis. Dr. Girard has authored 120+ papers in top Ophthalmology and Engineering journals, has given 50+ invited talks, has received 30+ research grants & 20+ research awards.
Michael Girard, PhD
First published on: September 29, 2021
Last modified on: April 17, 2024